www.genomeweb.com Open in urlscan Pro
2606:4700::6812:1c92  Public Scan

Form analysis
2 forms found in the DOM

GET /elastic-search

<form action="/elastic-search" method="get" id="views-exposed-form-search-autocomplete-page" accept-charset="UTF-8">
  <div class="js-form-item form-item form-element__textfield">
    <input class="elastic-autocomplete-input form-autocomplete form-text form-item__textfield ui-autocomplete-input" placeholder="Enter your keywords" data-drupal-selector="edit-search-phrase"
      data-autocomplete-path="/admin/view_content/search_autocomplete" type="text" id="edit-search-phrase" name="search_phrase" value="" size="30" maxlength="128" data-once="autocomplete" autocomplete="off">
  </div>
  <div class="js-form-item form-item form-element__submit">
    <button class="button button--icon js-form-submit form-submit" aria-label="button" title="Search">
      <svg class="icon">
        <use xlink:href="/profiles/custom/crain_core/themes/custom/gweb/dist/icons.svg#magnifying-glass"></use>
      </svg>
    </button>
  </div>
  <div data-drupal-selector="edit-actions" class="form-actions js-form-wrapper form-wrapper" id="edit-actions"></div>
</form>

GET /elastic-search

<form action="/elastic-search" method="get" id="views-exposed-form-search-autocomplete-page" accept-charset="UTF-8">
  <div class="js-form-item form-item form-element__textfield">
    <input class="elastic-autocomplete-input form-autocomplete form-text form-item__textfield ui-autocomplete-input" placeholder="Enter your keywords" data-drupal-selector="edit-search-phrase"
      data-autocomplete-path="/admin/view_content/search_autocomplete" type="text" id="edit-search-phrase" name="search_phrase" value="" size="30" maxlength="128" data-once="autocomplete" autocomplete="off">
  </div>
  <div class="js-form-item form-item form-element__submit">
    <button class="button button--icon js-form-submit form-submit" aria-label="button" title="Search">
      <svg class="icon">
        <use xlink:href="/profiles/custom/crain_core/themes/custom/gweb/dist/icons.svg#magnifying-glass"></use>
      </svg>
    </button>
  </div>
  <div data-drupal-selector="edit-actions" class="form-actions js-form-wrapper form-wrapper" id="edit-actions"></div>
</form>

Text Content

Skip to main content


SISTER PUBLICATION LINKS

 * GenomeWeb
 * 360Dx
 * Precision Medicine Online
 * PMLS Events

 * RSS Feeds
 * Visit GenomeWeb on Twitter
 * Visit GenomeWeb on LinkedIn

Premium Trial:

Request an Annual Quote


USER ACCOUNT MENU

 * My GenomeWeb
   * Profile
   * Newsletters
   * My Topics
   * Reading List
   * Log out

Log in
Subscribe
Menu
Close Menu


MAIN NAVIGATION

 * My GenomeWeb
   * Profile
   * Newsletters
   * My Topics
   * Reading List
   * Log out
 * Business & Policy
   * Business News
   * Research Funding
   * Policy & Legislation
   * Regulatory News
   * Reimbursement
 * Technology
   * Microarrays & Multiplexing
   * PCR
   * Informatics
   * Sequencing
   * Mass Spec
   * Sample Prep
   * Gene Silencing/Gene Editing
   * Synthetic Biology
   * Spatial Biology
 * Research
   * Genetic Research
   * Gene Expression Research
   * Epigenetics Research
   * Proteomics & Protein Research
   * Cell Biology Research
 * Diagnostics
   * Molecular Diagnostics
   * Companion Diagnostics
   * Biomarker Discovery & Validation
   * Drug Discovery & Development
   * Clinical Sequencing
   * Liquid Biopsy
 * Disease Areas
   * Cancer
   * Infectious Disease
   * Cardiovascular Disease
   * Neurological & Psychological Disease
   * Autoimmune Disease
   * Inherited Disease
   * Reproductive Health
   * Respiratory
   * Gastrointestinal
   * COVID-19
 * Applied Markets
 * Resources
   * Webinars
   * eCase Study Videos
   * The Scan
   * White Papers
   * Job Listings
   * New Products
   * People in the News
   * Genomics: Clinical Implementation
   * Advances in Clinical Genomics Profiling
   * Partner Content





BREADCRUMB

 1. Home
 2. Business, Policy & Funding
 3. Business News

Premium Trial:

Request an Annual Quote

Log in
Subscribe



GENEDX, PROGNOS HEALTH PARTNER ON RARE DISEASE PATIENT DATA TO SHORTEN
'TREATMENT ODYSSEY'

Jul 19, 2023 | staff reporter
Save for later

NEW YORK – GeneDx said Wednesday that it has formed a strategic partnership with
Prognos Health to help the latter's life sciences clients suggest therapies for
patients newly diagnosed with rare diseases. The firms hope to apply real-world
genomic data to shorten what they called the "treatment odyssey."

Under the partnership, New York-based Prognos will integrate de-identified
whole-genome and whole-exome sequencing data from GeneDx into its Prognos
Marketplace, where pharmaceutical companies, healthcare providers, and
researchers can purchase custom patient cohorts. The partners hope that this
combination will improve the ability to match newly diagnosed patients with US
Food and Drug Administration-approved medications.

"With the rare disease genomics data and expertise available to us through
partners like GeneDx, our life science clients can leverage the Prognos
Marketplace to bring about a paradigm shift in the treatment of rare diseases,"
Prognos Health CEO Sundeep Bhan said in a statement. "This partnership further
enables us to provide actionable insights in rare disease that can help
clinicians make more informed decisions and ensure patients receive the right
treatment at the right time."

Kareem Saad, chief transformation officer of Stamford, Connecticut-based GeneDx,
said that its goal has always been to speed up diagnostics and treatment for
patients. "This partnership gives us the opportunity to … connect clinicians and
their patients with rare diseases to appropriate treatment options and
ultimately improve health and health economic outcomes," he said.


TO READ THE FULL STORY…

Register for Free.

…and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?

Login Now



FILED UNDER

Business News
Informatics
Molecular Diagnostics
North America
collaboration
rare disease
Inherited Disease
data integration
GeneDx


WE RECOMMEND

 1. Rebranded GeneDx Bets Future on Whole-Exome, Whole-Genome Sequencing in
    Pediatric Rare Disease
    Neil Versel, GenomeWeb, 2023
 2. Dante Genomics, TMA Precision Health Partner for Rare Disease Diagnostics
    staff reporter, GenomeWeb, 2022
 3. Illumina, Henry Ford Health Partner on Genomic Testing for Cardiovascular
    Patients
    staff reporter, GenomeWeb, 2023
 4. Centogene to Offer Rare, Neurodegenerative Genomic Data for Rare
    Neurodegenerative Diseases on BC Platforms Network
    staff reporter, GenomeWeb, 2022

 1. Centogene to Offer Genomic Data for Rare Neurodegenerative Diseases on BC
    Platforms Network
    staff reporter, GenomeWeb, 2022
 2. Illumina, Genetic Alliance Launch $120M Global Whole-Genome Sequencing
    Program
    staff reporter, GenomeWeb, 2021
 3. Genomenon Partners With Neurodevelopmental Disease Groups on Drug
    Development
    staff reporter, GenomeWeb, 2022
 4. Broad Institute Launches $1K Sample-to-Report Clinical Whole-Genome
    Sequencing Service
    Huanjia Zhang, GenomeWeb, 2023

Powered by
 * Privacy policy
 * Do not sell my personal information
 * Google Analytics settings


I consent to the use of Google Analytics and related cookies across the TrendMD
network (widget, website, blog). Learn more
Yes No


Breaking News


 * 23ANDME LAYS OFF 71 THERAPEUTICS-RELATED EMPLOYEES AS GSK PARTNERSHIP ENDS
   AND Q1 REVENUES SLIDE


 * QIAGEN REPORTS 9 PERCENT NON-COVID SALES GROWTH IN Q2, CUTS FULL-YEAR
   GUIDANCE


 * VERACYTE Q2 SALES UP 24 PERCENT, DRIVEN BY PROSTATE AND THYROID CANCER TESTS


 * INVITAE Q2 REVENUES FALL 12 PERCENT AS FIRM LOWERS FULL-YEAR GUIDANCE


 * SEER Q2 REVENUES UP 11 PERCENT, CUTS 2023 GUIDANCE BY ROUGHLY A THIRD


The Scan


ANALYSIS OF NEW DRUG APPROVALS SUGGESTS RELIANCE ON LESS RIGOROUS STANDARDS

In JAMA Network Open, researchers examine FDA's novel drug approval data to find
a trend toward less rigorous standards in drug approvals.


GWAS IDENTIFIES LOCI LINKED TO BINGE EATING DISORDER

In a genome-wide association study appearing in Nature Genetics, researchers
home in on three loci tied to binge eating disorder.


BLOOD DNA METHYLATION-BASED ASSAY FOR EARLY DIAGNOSIS OF BREAST CANCER

In Nature Communications, researchers describe a new assay that uses differences
in DNA methylation patterns to distinguish breast cancer patients and controls.


EQTL STUDY UNCOVERS NEW CANDIDATE GENES FOR ADIPOSE TISSUE BIOLOGY

In BMC Genomics, researchers report that a study of Greek individuals uncovered
additional genes with cis-eQTLs in adipose tissue.

What's Popular?


 1. PACIFIC BIOSCIENCES, GENEDX, UW COLLABORATE ON GOOGLE-FUNDED STUDY OF WGS IN
    NEONATAL CARE


 2. DISTRICT COURT ISSUES INJUNCTION PROHIBITING FALSE ADVERTISING IN
    NATERA-CAREDX LEGAL ROW


 3. PREPRINT CASTS DOUBT ON STUDY UNDERPINNING MICROBIOME-BASED CANCER DX TEST
    FROM MICRONOMA
    PREMIUM


 4. QUANTUM-SI EXPERIENCING BUMPY ROLLOUT OF PLATINUM PROTEOMICS SYSTEM
    PREMIUM


 5. PACIFIC BIOSCIENCES TO BUILD 'HIGH-THROUGHPUT ONSO' FOLLOWING $110M APTON
    BIOSYSTEMS ACQUISITION
    PREMIUM




SPONSORSHIPS





FOOTER

 * About us
 * Advertise
 * Contact
 * FAQ
 * Jobs
 * Sitemap
 * Submit a Tip

Subscribe

Privacy Policy.  Terms & Conditions. Copyright © 2023 GenomeWeb, a business unit
of Crain Communications.  All Rights Reserved.

Our site uses cookies and related technologies, as described in our 
Datenschutzerklärung, for purposes that may include site operation, analytics,
enhanced user experience, or advertising. You may choose to consent to our use
of these technologies or manage your own preferences.
Akzeptieren Ablehnen Einstellungen verwalten